Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

Multiple Sclerosis Centers of Excellence


Quick Links

Veterans Crisis Line Badge
My healthevet badge
EBenefits Badge
Pause Play

Progressive MS Webinar

Register for our March 2021 webinar on progressive MS, a collaboration with the National MS Society and Paralyzed Veterans of America.

Learn more »

COVID-19 Update

COVID-19 & Vaccine Information

Get the latest MS news on the COVID-19 virus and vaccine.

Learn more »


Generic & Biosimilar DMTs

The field of MS is seeing an explosion of new US Federal Drug Administration approved generic and biosimilar MS disease modifying therapies.

Learn more »


Multiple Sclerosis Centers of Excellence

MSCoE LogoThe Multiple Sclerosis Centers of Excellence (MSCoE) are dedicated to furthering the understanding of multiple sclerosis (MS), its impact on Veterans, and effective treatments to help manage MS. By partnering with Veterans, caregivers, health care professionals, MS advocates, Veteran service organizations, and community health care institutes, MSCoE strives to minimize impairment and maximize quality of life for Veterans with MS.

MSCoE Network


VA MS Publications

Veteran Features

map of USMSCoE Network

MSCoE East and West have developed a national network of MS Regional Programs and MS Support Programs within the VA.

Given the size of the population of Veterans with MS seeking treatment in VA and their distribution across the country, it is feasible to provide access to high quality subspecialty care through a hub and spoke network with designated MS Regional Programs supporting local facilities. 

Each Veterans Integrated Service Network (VISN) will have at least one MS Regional Program that will serve as a source for MS specialty consultation and education. 

white figure talking through microphoneAnnouncements

December 2020: COVID-19 Vaccination for Veterans with MS

While people with MS were not included in the trials of the COVID-19 vaccines, there are no significant concerns that any of the COVID-19 vaccines increase the risk of infection, MS relapse, or MS worsening in people with MS. If you have MS, the potential benefits of receiving a COVID vaccine for you and your family generally outweigh the potential risks. There are no data supporting that any one of the vaccines offer specific unique advantages or disadvantages for people with MS or related diseases.

For most MS medications we anticipate that the vaccine should have full efficacy. For those on “B-cell therapies” such as rituximab (Rituxan, Truxima, Ruxience), ocrelizumab (Ocrevus), or ofatumumab (Kesimpta) the protection from the vaccine may be reduced based on research with other vaccines. Despite the reduced response we still think the benefits of vaccination outweigh the risk. In general our recommendation for people taking the B-cell therapies is to schedule the vaccination within a few weeks prior to your next scheduled infusion. Do not skip an infusion without talking to your MS doctor.

More information can be found at:

Centers for Disease Control

World Health Organization

National MS Society

December 2020

The VA MS Centers of Excellence are discontinuing the bi-annual printed newsletter and moving to an electronic version that will be e-mailed directly to Veterans with MS quarterly. Please go to the Veteran newsletter page if you would like to receive the e-letter.

October 2020

On Veterans Day, November 11, 2020, we take time to honor the brave and selfless Americans who have served in the United States Armed Forces, and to recognize the time, commitment and sacrifices of our service members who protect the ideals and freedoms that we cherish. We also take time on this day to remember the sacrifices made at home by the families and loved ones of our service members.

2020 Veteran Day Image

May 2020

MSCoE staff and associates authored four articles for the April 2020 issue of Federal Practitioner.

Chris W. Hollen, MD, M. Mateo Paz Soldán, MD, PhD, John R. Rinker, II, MD and Rebecca I. Spain, MD, MSPH. The Future of Progressive MS Therapies. Fed Pract. 2020 Apr;37(Suppl 1):S43-S49. (full article)

Michelle H. Cameron, MD, PT, MCR, Jodie K. Haselkorn, MD, MPH and Mitchell T. Wallin, MD, MPH. The MS Centers of Excellence: A Model of Excellence in the VA. Fed Pract. 2020 Apr; 37(Suppl 1): S6–S10. (full article)

Mitchell T. Wallin, MD, MPH, Ruth Whitham, MD, Heidi Maloni, PhD, Shan Jin, PhD, Jonathan Duckart, Jodie Haselkorn, MD, MPH and William J. Culpepper, PhD. The MS Surveillance Registry: A Novel Interactive Database Within the Veterans Health Administration. Fed Pract. 2020 Apr; 37(Suppl 1): S18–S23. (full article)

Kathryn Tortorice, PharmD, BCPS and Natasha Antonovich, PharmD, BCPS. MS Medications in the VHA: Delivering Specialty, High-Cost, Pharmacy Care in a National System. Fed Pract. 2020 Apr; 37(Suppl 1): S36–S42. (full article)

April 2020

If you push a manual wheelchair or use other types of assistive technology (AT), there are unique precautions you should take related to hand washing. COVID-19 can survive on the surfaces of your wheelchair or AT which you come in frequent contact with, such as the handrims. Any virus that might be on your hands is transferred to your handrims as you push your wheelchair. Guidance on protecting yourself and your loved ones can be found within the following PDF.

March 2020

Veterans with MS, families, and MS health care professionals have questions regarding MS and COVID19. The MS Centers of Excellence are watching the situation closely and support the guidance from VA Central Office (VACO COVID19), the Centers for Disease Control (CDC COVID19), and the National MS Society (NMSS COVID19). Please follow these links for the latest information.

At this time, Veterans with MS are not known to be at increased risk of COVID-19 per se, and general precautions should be taken by all Veterans with MS, their families, and their providers. Follow your facility guidance on inpatient and outpatient procedures. We encourage the use of telehealth and/or phone call visits in place of in-person visits when possible.

The more immunosuppressive MS disease-modifying therapies (DMT) including ocrelizumab, rituximab, alemtuzumab, and cladribine may carry a higher risks regarding COVID19. The decision to start, continue, delay dosing, or stop those DMTs should be decided on a case by case basis always considering factors of age, medical comorbidities, disability, etc.

Links are provided as a convenience and for informational purposes only. They do not constitute an endorsement or an approval by MSCoE of any of the products, services, or opinions of the organization. MSCoE bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links. Contact the external site for answers to questions regarding its content.

man reading a magazine while sitting at a tableVA MS Publications

The VA ranks as one of the nation’s leaders in health research. Thousands of studies are conducted at VA medical centers, outpatient clinics, and nursing homes each year. This research has significantly contributed to advancements in health care for Veterans and other Americans from every walk of life.

Learn about MSCoE research on our Professionals and Veterans research pages.

Recent VA Provider Publications

N-Acetylglucosamine Drives Myelination by Triggering Oligodendrocyte Precursor Cell Differentiation

MS Spasticity: Take Control for Ambulatory Adults: Protocol for a Randomized Controlled Trial

Telemedicine and MS: A Comprehensive Literature Review

CNS Inflammatory Demyelinating Disorders: MS, NMOSD and MOG Antibody Associated Disease

Approaches to Remyelination Therapies in MS

Cross-Sectional Survey of Complementary and Alternative Medicine Used in Oregon and Southwest Washington to Treat MS: A 17-Year Update

Phase I Randomized Trial of Liothyronine for Remyelination in MS: A Dose-Ranging Study with Assessment of Reliability of Visual Outcomes

Goal Pursuit, Goal Adjustment, and Pain in Middle-Aged Adults Aging With Physical Disability

Who is not coming to clinic? A predictive model of excessive missed appointments in persons with MS

Protocol for a systematically-developed, phase I/II, single-blind randomized controlled trial of treadmill walking exercise training effects on cognition and brain function in persons with MS

Physical Activity and Depression in MS: The Mediating Role of Behavioral Activation

Disclaimer: Links are provided as a convenience and for informational purposes only. They do not constitute an endorsement or an approval by MSCoE of any of the products, services, or opinions of the organization. MSCoE bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links. Contact the external site for answers to questions regarding its content.

flagVeteran Features


We are fortunate to have Veterans share their stories of living with MS. These stories are filled with life's challenges, the value of family and friends, lots of hopefulness, with a little sense of humor thrown in. We hope you will enjoy reading these stories and in a small way feel connected to others that are living with this disease.

YouTube Videos

Our YouTube series covers a variety issues effecting Veterans with MS. Each video shares perspectives from Veterans and their health care team.